Research & Publications
Dr. Longbrake directs the clinical and translational research program in neuroimmunology at Yale University. Her current work focuses on the relationships between the microbiome/metabolome, multiple sclerosis, and the immunomodulatory medications used to treat the disease. She is also involved in clinical trials examining whether short courses of immunotherapy at the very earliest stages of MS can lead to sustained remission.
Multiple Sclerosis; Neuromyelitis Optica; Autoimmune Diseases of the Nervous System
Public Health Interests
Genetics, Genomics, Epigenetics; Immunology; Nutrition; Microbiome